Related Experiment Video
Updated: Jun 11, 2026
Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity
Published on: July 1, 2014
Structural and functional glymphatic abnormalities in major depressive disorder and bipolar disorder: A multimodal
Lirong Fu1, Juanjuan Ren1, Xiaoxia Lei1
1Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Background:
The glymphatic system is essential for cerebral waste clearance. This study evaluated glymphatic function in major depressive disorder (MDD) and bipolar disorder (BD) by combining diffusion tensor imaging along the perivascular space (DTI-ALPS) and global blood‑oxygen-level-dependent (gBOLD)-cerebrospinal fluid (CSF) coupling, exploring associations with affective, sleep, and cognitive symptoms.
Methods:
We recruited 52 MDD patients, 31 BD patients, and 52 healthy controls (HCs) for multimodal magnetic resonance imaging (MRI). Glymphatic function was assessed via DTI-ALPS and gBOLD-CSF coupling. Standardized scales evaluated depression, anxiety, sleep disturbances, cognition, and anhedonia. Inter-group comparisons, correlation, regression, mediation, and receiver operating characteristic (ROC) curve analysis were performed.
Results:
MDD and BD patients exhibited significantly reduced DTI-ALPS indices and gBOLD-CSF coupling compared to HCs, with no significant differences between patient groups. Exploratory analyses indicated these indirect imaging markers were intercorrelated weakly but significantly. Additionally, modality-specific alterations correlated with cognitive decline and increased anhedonia in MDD, and poorer sleep in BD. ROC analysis showed the joint imaging model provided modest diagnostic performance for distinguishing patients from HCs, which improved when integrated with clinical variables. Furthermore, mediation analysis suggested gBOLD-CSF coupling statistically mediated the association between disease status and affective symptoms.
Conclusions:
Glymphatic impairment is a shared feature of MDD and BD. DTI-ALPS and gBOLD-CSF coupling serve as complementary, indirect biomarkers linked to core clinical features. While causal relationships remain to be elucidated, targeting glymphatic function may offer a novel therapeutic avenue for mood disorders.
